|
Table 1: Demographic and clinical characteristics among groups at baseline assessment. |
||||
|
|
Control (N = 44) n (%) |
Ketamine (N = 46) n (%) |
Statistics |
p |
|
Age (years)* |
69.4 ± 5.3 |
69.7 ± 7.9 |
t = -0.21 |
0.83 |
|
Midazolam dose (mg)* |
1.08 ± 0.5 |
0.90 ± 0.5 |
t = 1.60 |
0.11 |
|
Fentanyl dose (µg)* |
122.0 ± 43 |
106.5 ± 42.6 |
t = 1.71 |
0.90 |
|
Sex |
|
|
χ2 = 2.8 |
0.09 |
|
Male |
19 (43.2) |
28 (60.9) |
|
|
|
Female |
25 (56.8) |
18 (39.1) |
|
|
|
ASA functional capacity |
|
|
χ2 = 0.61 |
0.73 |
|
I |
1 (2.3) |
2 (4.3) |
|
|
|
II |
17 (38.6) |
20 (43.5) |
|
|
|
III |
26 (59.1) |
24 (52.2) |
|
|
|
Diagnosis |
|
|
χ2 = 7.6 |
0.10 |
|
Cataract |
17 (38.6) |
20 (43.5) |
|
|
|
Retinal detachment |
11 (25.0) |
3 (6.5) |
|
|
|
Detachment + cataract |
6 (13.6) |
5 (10.9) |
|
|
|
Vitreous hemorrhage |
2 (4.5) |
6 (13.0) |
|
|
|
Hemorrhage + cataract |
8 (18.2) |
12 (26.1) |
|
|
|
Type of surgery |
|
|
χ2 = 3.4 |
0.48 |
|
ECCE and IOL implantation |
12 (27.3) |
12 (26.1) |
|
|
|
Vitrectomy |
13 (29.5) |
7 (15.2) |
|
|
|
Vitrectomy + phacoemulsification |
4 (9.1) |
4 (8.7) |
|
|
|
Vitrectomy + ECCE + IOL |
6 (13.6) |
10 (21.7) |
|
|
|
Phacoemulsification |
9 (20.5) |
13 (28.3) |
|
|
|
ECCE = extracapsular cataract extraction; IOL = intraocular lens implantation; SD = standard deviation. * Values expressed as mean ± standard deviation; χ2 = Chi-square test; t = t-student test. |
||||